A pharmacist may identify a medication problem in minutes. Resolving it can take much longer.
A proper response may require reviewing records, speaking with the patient, documenting the intervention, contacting another healthcare professional, or arranging follow-up. Those tasks sit alongside dispensing and operational responsibilities that continue throughout the day.
That is why a pharmacist shortage is not only a question of headcount. Tight pharmacist staffing and rising pharmacist workload can also create a shortage of protected clinical time.
MDForLives surveyed pharmacists across the USA, UK, Canada, Italy, France and Germany. The detailed findings are available in the MDForLives Pharmacist Patient Care Insight Report. The survey reflects pharmacists’ professional experiences of direct patient care and the operating conditions around it.
The clinical role is expanding faster than the working day
In the MDForLives survey, 45.7% said their role in direct patient care had expanded significantly over the previous three years, while 38.0% reported moderate expansion.
The important change is not only the number of services pharmacists provide. Medication review, adherence counseling, vaccination, screening and chronic disease support can require assessment, conversation, documentation and follow-up.
If those responsibilities expand without the workflow changing around them, more clinical responsibility can simply become more competing work. Role expansion therefore changes how time needs to be designed, not only what pharmacists are allowed or expected to do.
Pharmacist shortage becomes a time problem when capacity is full
When organizations discuss pharmacist staffing, the first question is often how many pharmacists are available. Headcount alone, however, does not show how much clinical capacity exists.
The same staffing level can create a very different room for patient care depending on prescription volume, patient complexity, administrative work, and support from the wider pharmacy team.
In the survey, 78.6% selected workload, staffing, or limited consultation time as a main factor limiting greater clinical responsibility.
The deeper message is that capability can exist without capacity. A pharmacist may recognize a medication issue and know what needs to happen next but still lack uninterrupted time to assess it properly and close the loop.
The useful workforce question therefore becomes: how much usable clinical time does the staffing model actually create?
Clinical care needs protected time, not spare time
In the survey, 34.4% of pharmacists said more than half of their working time was spent on direct clinical or patient-care activities beyond dispensing. Others delivered clinical care within much smaller portions of the day.
That variation matters. Occasional counseling around dispensing requires a different workflow from scheduled medication reviews, chronic disease support, or repeated follow-up. Pharmacist workload therefore becomes a design issue. If a service is expected to happen routinely, it cannot depend on whether the dispensing queue happens to be lighter that day.
Protecting clinical time means deciding what other work can be delegated, automated, redistributed, or scheduled differently. Without that decision, patient care continues to compete with operational work.
Incomplete information can use up the time
Only 27.8% of surveyed pharmacists reported full access to the clinical information they need for effective patient care.
A pharmacist may identify a potential medication issue but still need to confirm a diagnosis, laboratory result, allergy or recent treatment change before acting. That can mean extra calls, repeated history-taking, or a more cautious recommendation. This creates a second-time barrier.
Advances in AI in Pharmacy may help streamline information-related tasks and support pharmacy workflows, allowing pharmacists to focus more time on patient care.
Better information access does not replace professional judgment. It allows limited clinical time to be used on the decision itself rather than searching for the information needed to make it.
Clinical judgment still needs a clear route to action
Having time and information still does not guarantee that the pharmacist can resolve an issue directly.
The survey found that clinical severity and the patient’s immediate needs were the strongest influence on whether pharmacists intervened directly or referred. Scope of practice, information access, clinical support, time and referral pathways also shapes what happenes next.
Recognizing a problem is therefore only the first step. The pharmacist also needs clarity about what can be managed directly, what requires collaboration, when referral is appropriate, and how responsibility moves safely to the next professional.
Telehealth in Pharmacy may help extend access to pharmacist-led consultations and connect patients with appropriate healthcare professionals when in-person care is difficult to access.
A bigger clinical role needs workload redesign, not just role expansion
The survey’s final direction brings these pressures together. 68.0% selected protected consultation time, staffing and reduced administrative workload as changes that would strengthen direct patient care. The same proportion selected broader scope of practice and reimbursement for clinical services.
Protected time without appropriate authority can leave expertise underused. Broader scope without staffing can add responsibility to an already full workload. Better information without collaborative pathways can still leave recommendations disconnected from the wider care team.
For pharmacy leaders and allied healthcare professionals, sustainable role expansion therefore requires an operating model in which staffing, protected time, information access, scope, reimbursement and collaboration reinforce one another.
The future of pharmacy will depend on balancing digital innovation, expanded clinical services, and workforce capacity to support sustainable, patient-centered care.
Closing perspective: the missing resource may be usable clinical time
The MDForLives findings describe pharmacists contributing well beyond medicine supply while working against limits of workload, staffing and consultation time.
A pharmacist shortage can therefore appear in more than one form. It may be an unfilled position, but it can also appear as insufficient clinical capacity inside a fully occupied workflow.
That distinction matters because adding responsibility does not create the time required to deliver it.
The more useful question is what clinical work the pharmacy expects, how much time that work needs, who supports the remaining workload, what information pharmacists can access, what decisions they can make and how the wider care team stays connected.
When those elements are designed together, the pharmacist role in patient care has room to grow without relying on spare time.
Frequently Asked Questions
How can a pharmacist shortage affect patient care?
A pharmacist shortage or tight staffing model can reduce the time available for medication reviews, counseling, follow-up and other patient-care activities when dispensing and operational demands remain high.
How does pharmacist staffing affect clinical pharmacy services?
Pharmacist staffing influences how much protected time can be allocated to assessment, counseling, documentation and follow-up. The appropriate model depends on patient volume, service mix, workflow and available support.
How can pharmacist workload limit the pharmacist role in patient care?
High pharmacist workload can make uninterrupted consultation time difficult to protect. Clinical services may then compete with dispensing, administrative tasks and other responsibilities.
Does the MDForLives study measure pharmacist burnout?
No. Pharmacist burnout was not measured as a standalone outcome. The survey examined workload, staffing, consultation time, information access, scope, reimbursement and collaboration as factors affecting greater clinical responsibility.
What could help pharmacists take on a bigger clinical role?
The survey points toward protected consultation time, appropriate staffing, lower administrative burden, broader scope and reimbursement, better access to patient information, and stronger clinical training and collaboration.
